Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease
- PMID: 19481608
- PMCID: PMC2746706
- DOI: 10.1016/j.neuroimage.2009.05.063
Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease
Abstract
Amyloid beta (Abeta) is the primary component of Alzheimer's disease (AD) plaques, a key pathological feature of the disease. Metal ions of zinc (Zn), copper (Cu), iron (Fe), and calcium (Ca) are elevated in human amyloid plaques and are thought to be involved in neurodegeneration. Transgenic mouse models of AD also exhibit amyloid plaques, but fail to exhibit the high degree of neurodegeneration observed in humans. In this study, we imaged the Zn, Cu, Fe, and Ca ion distribution in the PSAPP transgenic mouse model representing end-stage AD (N=6) using synchrotron X-ray fluorescence (XRF) microprobe. In order to account for differences in density in the plaques, the relative protein content was imaged with synchrotron Fourier transform infrared microspectroscopy (FTIRM) on the same samples. FTIRM results revealed a 61% increase in protein content in the plaques compared to the surrounding tissue. After normalizing to protein density, we found that the PSAPP plaques contained only a 29% increase in Zn and there was actually less Cu, Fe, and Ca in the plaque compared to the surrounding tissue. Since metal binding to Abeta is thought to induce redox chemistry that is toxic to neurons, the reduced metal binding in PSAPP mice is consistent with the lack of neurodegeneration in these animals. These findings were in stark contrast to the high metal ion content observed in human AD plaques, further implicating the role of metal ions in human AD pathology.
Figures


Similar articles
-
Synchrotron-based infrared and X-ray imaging shows focalized accumulation of Cu and Zn co-localized with beta-amyloid deposits in Alzheimer's disease.J Struct Biol. 2006 Jul;155(1):30-7. doi: 10.1016/j.jsb.2005.09.004. Epub 2005 Nov 14. J Struct Biol. 2006. PMID: 16325427
-
Virtual histology of Alzheimer's disease: Biometal entrapment within amyloid-β plaques allows for detection via X-ray phase-contrast imaging.Acta Biomater. 2023 Oct 15;170:260-272. doi: 10.1016/j.actbio.2023.07.046. Epub 2023 Aug 11. Acta Biomater. 2023. PMID: 37574159
-
Iron, Copper, and Zinc Concentration in Aβ Plaques in the APP/PS1 Mouse Model of Alzheimer's Disease Correlates with Metal Levels in the Surrounding Neuropil.ACS Chem Neurosci. 2017 Mar 15;8(3):629-637. doi: 10.1021/acschemneuro.6b00362. Epub 2016 Dec 22. ACS Chem Neurosci. 2017. PMID: 27958708
-
Abeta as a bioflocculant: implications for the amyloid hypothesis of Alzheimer's disease.Neurobiol Aging. 2002 Nov-Dec;23(6):1051-72. doi: 10.1016/s0197-4580(01)00342-6. Neurobiol Aging. 2002. PMID: 12470802 Review.
-
Redox-active metals, oxidative stress, and Alzheimer's disease pathology.Ann N Y Acad Sci. 2004 Mar;1012:153-63. doi: 10.1196/annals.1306.012. Ann N Y Acad Sci. 2004. PMID: 15105262 Review.
Cited by
-
A new method to image heme-Fe, total Fe, and aggregated protein levels after intracerebral hemorrhage.ACS Chem Neurosci. 2015 May 20;6(5):761-70. doi: 10.1021/acschemneuro.5b00037. Epub 2015 Mar 2. ACS Chem Neurosci. 2015. PMID: 25695130 Free PMC article.
-
Metal-deficient aggregates and diminished copper found in cells expressing SOD1 mutations that cause ALS.Front Aging Neurosci. 2014 Jun 16;6:110. doi: 10.3389/fnagi.2014.00110. eCollection 2014. Front Aging Neurosci. 2014. PMID: 24982630 Free PMC article.
-
Metal Imbalance in Neurodegenerative Diseases with a Specific Concern to the Brain of Multiple Sclerosis Patients.Int J Mol Sci. 2020 Nov 30;21(23):9105. doi: 10.3390/ijms21239105. Int J Mol Sci. 2020. PMID: 33266021 Free PMC article. Review.
-
Increased brain iron coincides with early plaque formation in a mouse model of Alzheimer's disease.Neuroimage. 2011 Mar 1;55(1):32-8. doi: 10.1016/j.neuroimage.2010.11.073. Epub 2010 Nov 30. Neuroimage. 2011. PMID: 21126592 Free PMC article.
-
Using Redox Proteomics to Gain New Insights into Neurodegenerative Disease and Protein Modification.Antioxidants (Basel). 2024 Jan 20;13(1):127. doi: 10.3390/antiox13010127. Antioxidants (Basel). 2024. PMID: 38275652 Free PMC article. Review.
References
-
- Arispe N, Pollard HB, Rojas E. The ability of amyloid β-protein [AβP (1–40)] to form Ca2+ channels provides a mechanism for neuronal death in Alzheimer’s disease. Ann N Y Acad Sci. 1994;747:256–266. - PubMed
-
- Atwood CS, Martins RN, Smith MA, Perry G. Senile plaque composition and posttranslational modification of amyloid-beta peptide and associated proteins. Peptides. 2002;23:1343–1350. - PubMed
-
- Atwood CS, Moir RD, Huang X, Scarpa RC, Bacarra NM, Romano DM, Hartshorn MA, Tanzi RE, Bush AI. Dramatic aggregation of Alzheimer Aβ by Cu(II) is induced by conditions representing physiological acidosis. J Biol Chem. 1998;273:12817–12826. - PubMed
-
- Atwood CS, Scarpa RC, Huang X, Moir RD, Jones WD, Fairlie DP, Tanzi RE, Bush AI. Characterization of copper interactions with alzheimer amyloid β peptides: identification of an attomolar-affinity copper binding site on amyloid β1–42. J Neurochem. 2000;75:1219–1233. - PubMed
-
- Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA, Copeland NG, Price DL, Sisodia SS. Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins. Neuron. 1997;19:939–945. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical